Brunner, H., Pacheco-Tena, C., Louw, I., Vega-Cornejo, G., Alexeeva, E., Appenzeller, S., et al. (2025). Erratum: Intravenous Golimumab in Children With Polyarticular-Course Juvenile Idiopathic Arthritis: Long-Term Extension of an Open-Label Phase III Study (The Journal of rheumatology (2024) 51 11 DOI: 10.3899/jrheum.2024-0298.) [Altro] [10.3899/jrheum.2024-0298.C1].

Erratum: Intravenous Golimumab in Children With Polyarticular-Course Juvenile Idiopathic Arthritis: Long-Term Extension of an Open-Label Phase III Study (The Journal of rheumatology (2024) 51 11 DOI: 10.3899/jrheum.2024-0298.)

Ruperto N.
2025

Altro
Erratum
adverse drug reaction; drug therapy; erratum; human; major clinical study; phase 3 clinical trial; side effect
English
2025
52
1069
Scopus ID 2-s2.0-105017598906 - PubMed ID 40763950 - WOS ID WOS:001591253800001
Brunner, H., Pacheco-Tena, C., Louw, I., Vega-Cornejo, G., Alexeeva, E., Appenzeller, S., et al. (2025). Erratum: Intravenous Golimumab in Children With Polyarticular-Course Juvenile Idiopathic Arthritis: Long-Term Extension of an Open-Label Phase III Study (The Journal of rheumatology (2024) 51 11 DOI: 10.3899/jrheum.2024-0298.) [Altro] [10.3899/jrheum.2024-0298.C1].
none
File in questo prodotto:
Non ci sono file associati a questo prodotto.

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/10281/604481
Citazioni
  • Scopus ND
  • ???jsp.display-item.citation.isi??? ND
Social impact